Ignite Creation Date:
2024-05-06 @ 2:21 PM
Last Modification Date:
2024-10-26 @ 1:29 PM
Study NCT ID:
NCT04296942
Status:
TERMINATED
Last Update Posted:
2022-01-11
First Post:
2020-03-04
Brief Title:
BN-Brachyury Entinostat Adotrastuzumab Emtansine and M7824 in Advanced Stage Breast Cancer BrEAsT
Sponsor:
National Cancer Institute NCI
Organization:
National Institutes of Health Clinical Center CC
Organization Data
Organization:
National Institutes of Health Clinical Center CC
Class:
NIH
Study ID:
200056
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Cancer Institute NCI
Lead Sponsor Class:
NIH
Responsible Party:
Fatima Karzai MD
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
National Cancer Institute NCI
Old Name:
None
Old Organization:
None